By Professor Ric Day

Journal articles

Mathieson S; Billot L; Maher CG; McLachlan AJ; Latimer J; Koes BW; Hancock MJ; Harris I; Day RO; Pik J; Jan S; Lin CWC, 2016, 'PRECISE - pregabalin in addition to usual care: Statistical analysis plan', Trials, 17, pp. 53, http://dx.doi.org/10.1186/s13063-016-1174-y

Fernon A; Nguyen A; Baysari M; Day R, 2016, 'A user-centred approach to designing an etool for gout management', Studies in Health Technology and Informatics, 227, pp. 28 - 33, http://dx.doi.org/10.3233/978-1-61499-666-8-28

Vaccher S; Kannangara DRW; Baysari MT; Reath J; Zwar N; Williams KM; Day RO, 2016, 'Barriers to care in gout: From prescriber to patient', Journal of Rheumatology, 43, pp. 144 - 149, http://dx.doi.org/10.3899/jrheum.150607

Martinello M; Schteinman A; Alavi M; Williams K; Dore GJ; Day R; Matthews GV, 2016, 'The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', ANTIVIRAL THERAPY, 21, pp. 127 - 132, http://dx.doi.org/10.3851/imp2984

Rasheed H; McKinney C; Stamp LK; Dalbeth N; Topless RK; Day R; Kannangara D; Williams K; Smith M; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; Lu L; Stahl EA; Choi HK; So A; Merriman TR, 2016, 'The toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and polynesian sample sets', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0147939

Day RO; Kamel B; Kannangara DRW; Williams KM; Graham GG, 2016, 'Xanthine oxidoreductase and its inhibitors: Relevance for gout', Clinical Science, 130, pp. 2167 - 2180, http://dx.doi.org/10.1042/CS20160010

Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO, 2016, 'Barriers to the treatment of gout: a community pharmacy perspective', Research in Social and Administrative Pharmacy, 12, pp. e31 - e31, http://dx.doi.org/10.1016/j.sapharm.2016.05.077

Cai X; Perez-Concha O; Coiera E; Martin-Sanchez F; Day R; Roffe D; Gallego B, 2016, 'Real-time prediction of mortality, readmission, and length of stay using electronic health record data', Journal of the American Medical Informatics Association, 23, pp. 553 - 561, http://dx.doi.org/10.1093/jamia/ocv110

Chung WH; Chang WC; Stocker SL; Juo CG; Graham GG; Lee MHH; Williams KM; Tian YC; Juan KC; Wu YJJ; Yang CH; Chang CJ; Lin YJ; Day RO; Hung SI, 2015, 'Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin', Annals of the Rheumatic Diseases, 74, pp. 2157 - 2164, http://dx.doi.org/10.1136/annrheumdis-2014-205577

McKinney C; Stamp LK; Dalbeth N; Topless RK; Day RO; Kannangara DRW; Williams KM; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; So A; Merriman TR, 2015, 'Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout', Arthritis Research and Therapy, 17, pp. 288, http://dx.doi.org/10.1186/s13075-015-0802-3

Merriman TR; Stamp LK; Dalbeth N; Topless R; Day R; Kannangara D; Williams K; Janssen M; Jansen T; Joosten LA; Radstake T; Riches PL; Tausche A-K; Liote F; So A; McKinney C, 2015, 'Epistatic Interaction of Functional Inflammasome Genetic Variants in Determining the Risk of Gout', ARTHRITIS & RHEUMATOLOGY, 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370860204715&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2015, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, 18, pp. 1783 - 1796, http://dx.doi.org/10.1111/hex.12170

Missiakos O; Baysari MT; Day RO, 2015, 'Identifying effective computerized strategies to prevent drug-drug interactions in hospital: A user-centered approach', International Journal of Medical Informatics, 84, pp. 595 - 600, http://dx.doi.org/10.1016/j.ijmedinf.2015.04.001

Ghosh D; McGann PM; Furlong TJ; Day RO, 2015, 'Febuxostat-associated rhabdomyolysis in chronic renal failure', Medical Journal of Australia, 203, pp. 107 - 108, http://dx.doi.org/10.5694/mja14.01404

Westbrook JI; Gospodarevskaya E; Li L; Richardson KL; Roffe D; Heywood M; Day RO; Graves N, 2015, 'Cost-effectiveness analysis of a hospital electronic medication management system', Journal of the American Medical Informatics Association, 22, pp. 784 - 793, http://dx.doi.org/10.1093/jamia/ocu014

Lin CWC; Day RO; Harris I; Maher CG; McLachlan A, 2015, 'Comparative efficacy trials with no placebo group cannot determine efficacy', BMJ (Online), 350, http://dx.doi.org/10.1136/bmj.h3292

Wang LW; He EYJ; Ghosh D; Day RO; Jones GRD; Subbiah RN; Holloway CJ, 2015, 'Severe carbon monoxide poisoning from waterpipe smoking: A public health concern', Medical Journal of Australia, 202, pp. 446 - 448, http://dx.doi.org/10.5694/mja14.01264

Day R; Lipworth W; Ghinea N, 2015, 'The Ethics Around Drug Labels and Generic Medicines', Therapeutic Innovation and Regulatory Science, 49, pp. 348 - 351, http://dx.doi.org/10.1177/2168479015577867

Fransen M; Agaliotis M; Nairn L; Votrubec M; Bridgett L; Su S; Jan S; March L; Edmonds J; Norton R; Woodward M; Day R; Buckland-Wright C; Bridges-Webb C; Heritier S; Jones G; Sambrook P; Speechly C; Vignon E; Jovanovic G; Jeram S; Dowd M; Champion M; Grealy S; Watson D; Vrataric A; Johnson C; White R; O'Connell P; Milwraith F; Kennedy D; Faulkes C; Bulton O; Johnson K, 2015, 'Glucosamine and chondroitin for knee osteoarthritis: A double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens', Annals of the Rheumatic Diseases, 74, pp. 851 - 858, http://dx.doi.org/10.1136/annrheumdis-2013-203954

Day RO, 2015, 'Prednisone for cardiac failure in patients with hypertension', Journal of Rheumatology, 42, pp. 739 - 740, http://dx.doi.org/10.3899/jrheum.150276

Hmar RC; Kannangara DRW; Ramasamy SN; Baysari MT; Williams KM; Day RO, 2015, 'Understanding and improving the use of allopurinol in a teaching hospital', Internal Medicine Journal, 45, pp. 383 - 390, http://dx.doi.org/10.1111/imj.12701

Machado GC; Maher CG; Ferreira PH; Pinheiro MB; Lin CWC; Day RO; McLachlan AJ; Ferreira ML, 2015, 'Efficacy and safety of paracetamol for spinal pain and osteoarthritis: Systematic review and meta-analysis of randomised placebo controlled trials', BMJ (Online), 350, http://dx.doi.org/10.1136/bmj.h1225

Westbrook JI; Li L; Lehnbom EC; Baysari MT; Braithwaite J; Burke R; Conn C; Day RO, 2015, 'What are incident reports telling us? A comparative study at two Australian hospitals of medication errors identified at audit, detected by staff and reported to an incident system', International Journal for Quality in Health Care, 27, pp. 1 - 9, http://dx.doi.org/10.1093/intqhc/mzu098

2015, 'Corrigendum to Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? [Intern Med J 45, (2015), 55-62], doi:10.1111/imj.12627', Internal Medicine Journal, 45, pp. 470 - 470, http://dx.doi.org/10.1111/imj.12751

Diasinos N; Baysari M; Kumar S; Day RO, 2015, 'Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines?', Internal Medicine Journal, 45, pp. 55 - 62, http://dx.doi.org/10.1111/imj.12627

Duong JK; Kumar SS; Furlong TJ; Kirkpatrick CM; Graham GG; Greenfield JR; Williams KM; Day RO, 2015, 'The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus', British Journal of Clinical Pharmacology, 79, pp. 617 - 623, http://dx.doi.org/10.1111/bcp.12525

Gallego B; Walter SR; Day RO; Dunn AG; Sivaraman V; Shah N; Longhurst CA; Coiera E, 2015, 'Bringing cohort studies to the bedside: framework for a ‘green button’to support clinical decision-making', Journal of comparative effectiveness research, 4, pp. 191 - 197

Inam S; Lipworth W; Kerridge I; Day R, 2014, 'A review of strategies to improve rational prescribing in asthma', Journal of Pharmacy Practice and Research, 44, pp. 195 - 200, http://search.informit.com.au/fullText;dn=931639746078946;res=IELHEA

Ghosh D; Williams KM; Graham GG; Nair P; Buscher H; Day RO, 2014, 'Multiple episodes of aspirin overdose in an individual patient: A case report', Journal of Medical Case Reports, 8, http://dx.doi.org/10.1186/1752-1947-8-374

Rasheed H; Topless R; Day R; Kannangara D; Williams K; Bradbury L; Brown M; Hill C; Lester S; Rischmueller M; Smith M; Andres M; Bardin T; Doherty M; Janssen M; Jansen T; Joosten L; Perez-Ruiz F; Radstake T; Riches PL; Roddy E; Tausche A-K; Stamp LK; Dalbeth N; Liote F; So A; McKinney C; Merriman TR, 2014, 'Association of the Toll-like Receptor 4 (TLR4) Gene with Gout.', ARTHRITIS & RHEUMATOLOGY, 66, pp. S1294 - S1295, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344384906196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Baysari MT; Adams K; Lehnbom EC; Westbrook JI; Day RO, 2014, 'iPad use at the bedside: A tool for engaging patients in care processes during ward rounds?', Internal Medicine Journal, 44, pp. 986 - 990, http://dx.doi.org/10.1111/imj.12518

Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2014, 'Diabetes Education: the Experiences of Young Adults with Type 1 Diabetes', Diabetes Therapy, 5, pp. 299 - 321, http://dx.doi.org/10.1007/s13300-014-0056-0

Perera V; Bies RR; Mo G; Dolton MJ; Carr VJ; McLachlan AJ; Day RO; Polasek TM; Forrest A, 2014, 'Optimal sampling of antipsychotic medicines: A pharmacometric approach for clinical practice', British Journal of Clinical Pharmacology, 78, pp. 800 - 814, http://dx.doi.org/10.1111/bcp.12410

Wiley J; Westbrook M; Greenfield JR; Day RO; Braithwaite J, 2014, 'Shared decision-making: The perspectives of young adults with type I diabetes mellitus', Patient Preference and Adherence, 8, pp. 423 - 435, http://dx.doi.org/10.2147/PPA.S57707

Ghinea N; Lipworth W; Kerridge I; Little M; Day RO, 2014, 'Ethics & evidence in medical debates: The case of recombinant activated factor VII', Hastings Center Report, 44, pp. 38 - 45, http://dx.doi.org/10.1002/hast.287

Perera V; Dolton MJ; McLachlan AJ; Carr VJ; Day RO, 2014, 'Pharmacometrics: An underused resource in Australian clinical research', Medical Journal of Australia, 200, pp. 82 - 83, http://dx.doi.org/10.5694/mja13.10663

Lipworth W; Doran E; Kerridge I; Day R, 2014, 'Challenges to pharmaceutical policymaking: Lessons from Australia's national medicines policy', Australian Health Review, 38, pp. 160 - 168, http://dx.doi.org/10.1071/AH13240

Kannangara DRW; Graham GG; Williams KM; Day RO, 2014, 'Hypouricemic effects of prednisone and allopurinol: An uneven playing field?', Canadian Journal of Cardiology, 30, pp. 376.e1, http://dx.doi.org/10.1016/j.cjca.2013.04.015

Lehnbom EC; Adams K; Day RO; Westbrook JI; Baysari MT, 2014, 'IPad use during ward rounds: An observational study', Studies in Health Technology and Informatics, 204, pp. 67 - 73, http://dx.doi.org/10.3233/978-1-61499-427-5-67

Baysari MT; Westbrook JI; Richardson K; Day RO, 2014, 'Optimising computerised alerts within electronic medication management systems: A synthesis of four years of research', Studies in Health Technology and Informatics, 204, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-427-5-1

Fransen M; Day RO, 2014, 'Response to A. G. Helg's comments on the LEGS study', Annals of the Rheumatic Diseases, 73, http://dx.doi.org/10.1136/annrheumdis-2014-205569

Williams CM; Maher CG; Latimer J; McLachlan AJ; Hancock MJ; Day RO; Lin C-WC, 2014, 'Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial', The Lancet, 384, pp. 1586 - 1596, http://dx.doi.org/10.1016/S0140-6736(14)60805-9

Kannangara DRW; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO, 2013, 'An audit of a therapeutic drug monitoring service for allopurinol therapy', Therapeutic Drug Monitoring, 35, pp. 863 - 866, http://dx.doi.org/10.1097/FTD.0b013e318299920a

Baysari MT; Oliver K; Egan B; Li L; Richardson K; Sandaradura I; Westbrook JI; Day RO, 2013, 'Audit and feedback of antibiotic use', Applied Clinical Informatics, 4, pp. 583 - 595, http://dx.doi.org/10.4338/ACI-2013-08-RA-0063

Arabadzhiyska PN; Baysari MT; Walter S; Day RO; Westbrook JI, 2013, 'Shedding light on junior doctors' work practices after hours', Internal Medicine Journal, 43, pp. 1321 - 1326, http://dx.doi.org/10.1111/imj.12223

Day RO; Graham GG, 2013, 'Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs)', British Journal of Sports Medicine, 47, pp. 1127, http://dx.doi.org/10.1136/bjsports-2013-f3195rep

Westbrook JI; Baysari MT; Li L; Burke R; Richardson KL; Day RO, 2013, 'The safety of electronic prescribing: Manifestations, mechanisms, and rates of system-related errors associated with two commercial systems in hospitals', Journal of the American Medical Informatics Association, 20, pp. 1159 - 1167, http://dx.doi.org/10.1136/amiajnl-2013-001745

Lewis JRR; Lipworth WL; Kerridge IH; Day RO, 2013, 'The economic evaluation of personalised oncology medicines: Ethical challenges', Medical Journal of Australia, 199, pp. 471 - 473, http://dx.doi.org/10.5694/mja13.10046

Ramasamy SN; Korb-Wells CS; Kannangara DRW; Smith MWH; Wang N; Roberts DM; Graham GG; Williams KM; Day RO, 2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0

Tea CK; Baysari MT; Day RO, 2013, 'Compliance with antibiotic prescribing policy: Perspectives of policymakers and prescribers', Australian Journal of Pharmacy, 94, pp. 74 - 77

Back to profile page